These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 28063904)

  • 21. Use of Spray-Dried Dispersions in Early Pharmaceutical Development: Theoretical and Practical Challenges.
    Li J; Patel D; Wang G
    AAPS J; 2017 Mar; 19(2):321-333. PubMed ID: 27896684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solid state nuclear magnetic resonance studies of hydroxypropylmethylcellulose acetyl succinate polymer, a useful carrier in pharmaceutical solid dispersions.
    Pugliese A; Hawarden LE; Abraham A; Tobyn M; Blanc F
    Magn Reson Chem; 2020 Nov; 58(11):1036-1048. PubMed ID: 31880823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pairwise polymer blends for oral drug delivery.
    Marks JA; Wegiel LA; Taylor LS; Edgar KJ
    J Pharm Sci; 2014 Sep; 103(9):2871-2883. PubMed ID: 24823790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
    Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
    J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-polymer solubility and miscibility: Stability consideration and practical challenges in amorphous solid dispersion development.
    Qian F; Huang J; Hussain MA
    J Pharm Sci; 2010 Jul; 99(7):2941-7. PubMed ID: 20127825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction and Construction of Drug-Polymer Binary System Thermodynamic Phase Diagram in Amorphous Solid Dispersions (ASDs).
    Hu Z; Xu P; Ashour EA; Repka MA
    AAPS PharmSciTech; 2022 Jun; 23(6):169. PubMed ID: 35715519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Site specific solubility improvement using solid dispersions of HPMC-AS/HPC SSL--mixtures.
    Zecevic DE; Meier R; Daniels R; Wagner KG
    Eur J Pharm Biopharm; 2014 Jul; 87(2):264-70. PubMed ID: 24768770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular implications of drug-polymer solubility in understanding the destabilization of solid dispersions by milling.
    Yang Z; Nollenberger K; Albers J; Qi S
    Mol Pharm; 2014 Jul; 11(7):2453-65. PubMed ID: 24897345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of phase diagrams and physical stability of drug-polymer solid dispersions.
    Lu J; Shah S; Jo S; Majumdar S; Gryczke A; Kolter K; Langley N; Repka MA
    Pharm Dev Technol; 2015 Jan; 20(1):105-17. PubMed ID: 25113671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of griseofulvin and hydroxypropylmethyl cellulose acetate succinate miscibility in ball milled solid dispersions.
    Al-Obaidi H; Lawrence MJ; Al-Saden N; Ke P
    Int J Pharm; 2013 Feb; 443(1-2):95-102. PubMed ID: 23299082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COSMOPharm: Drug-Polymer Compatibility of Pharmaceutical Amorphous Solid Dispersions from COSMO-SAC.
    Antolović I; Vrabec J; Klajmon M
    Mol Pharm; 2024 Sep; 21(9):4395-4415. PubMed ID: 39078049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-Term Physical Stability of PVP- and PVPVA-Amorphous Solid Dispersions.
    Lehmkemper K; Kyeremateng SO; Heinzerling O; Degenhardt M; Sadowski G
    Mol Pharm; 2017 Jan; 14(1):157-171. PubMed ID: 28043133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation and correlation of physical stability, dissolution behaviour and interaction parameter of amorphous solid dispersions of telmisartan: a drug development perspective.
    Dukeck R; Sieger P; Karmwar P
    Eur J Pharm Sci; 2013 Jul; 49(4):723-31. PubMed ID: 23684913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques.
    Meng F; Gala U; Chauhan H
    Drug Dev Ind Pharm; 2015; 41(9):1401-15. PubMed ID: 25853292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlationship of Drug-Polymer Miscibility, Molecular Relaxation and Phase Behavior of Dipyridamole Amorphous Solid Dispersions.
    Sharma J; Singh B; Agrawal AK; Bansal AK
    J Pharm Sci; 2021 Apr; 110(4):1470-1479. PubMed ID: 33333143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiscale Computational Modeling of the Nanostructure of Solid Dispersions of Hydroxypropyl Methylcellulose Acetate Succinate (HPMCAS) and Phenytoin.
    Huang W; Mandal T; Larson RG
    Mol Pharm; 2017 Oct; 14(10):3422-3435. PubMed ID: 28829134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting the formation and stability of amorphous small molecule binary mixtures from computationally determined Flory-Huggins interaction parameter and phase diagram.
    Pajula K; Taskinen M; Lehto VP; Ketolainen J; Korhonen O
    Mol Pharm; 2010 Jun; 7(3):795-804. PubMed ID: 20361760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analytical and Computational Methods for the Determination of Drug-Polymer Solubility and Miscibility.
    Thakore SD; Akhtar J; Jain R; Paudel A; Bansal AK
    Mol Pharm; 2021 Aug; 18(8):2835-2866. PubMed ID: 34041914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting Solubility/Miscibility in Amorphous Dispersions: It Is Time to Move Beyond Regular Solution Theories.
    Anderson BD
    J Pharm Sci; 2018 Jan; 107(1):24-33. PubMed ID: 29031973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of the thermal phase diagram of amorphous solid dispersions by Flory-Huggins theory.
    Zhao Y; Inbar P; Chokshi HP; Malick AW; Choi DS
    J Pharm Sci; 2011 Aug; 100(8):3196-3207. PubMed ID: 21416468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.